India tightens rules on prescription drug advertising by pharmacies

India's drug regulator has proposed stricter controls on how pharmacies and wholesalers advertise prescription-only medications, seeking to address growing concerns over unauthorised promotion and self-medication practices. The draft amendment represents an effort to strengthen existing pharmaceutical regulations and ensure compliance with guidelines restricting the publicity of drugs that should only be dispensed on doctor's orders.

The proposed rules target retail pharmacies and wholesale distributors engaging in promotion of prescription-only drugs through various channels. By restricting such advertising, authorities aim to prevent consumers from self-diagnosing and obtaining potent medications without proper medical supervision, a practice that can lead to adverse health outcomes and antibiotic resistance.

The government has opened a 30-day consultation window for stakeholders to submit feedback on the draft amendment. Industry bodies, pharmacy associations, medical professionals, and other interested parties are expected to provide their perspectives on the proposed restrictions and their potential impact on pharmaceutical business practices and consumer access to medicines.

The regulatory proposal reflects broader efforts by Indian health authorities to strengthen pharmaceutical oversight and promote rational drug use. Similar measures have been implemented in other jurisdictions to balance accessibility with public safety concerns surrounding prescription medications.